Amino Acid Substitutions in the Fusion Protein of Respiratory Syncytial Virus in Fukushima, Japan, During 2008–2023 and Their Effects
The Journal of Infectious Diseases · 2025
DOI: 10.1093/infdis/jiae636 ↗Kurz gefasst
Fachartikel in der Zeitschrift The Journal of Infectious Diseases, 2025. Verfasst von Hisao Okabe und 17 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pediatrics, School of Medicine, Fukushima Medical University, Fukushima City. Hauptthemen laut MEDLINE: Amino Acid Substitution, Respiratory Syncytial Virus Infections, Respiratory Syncytial Virus, Human, Viral Fusion Proteins. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 47 Literaturangaben. Gefördert von: Japan Agency for Medical Research and Development.
Abstract (Originalsprache)
Background
Amino acid (AA) substitutions in the fusion (F) protein of respiratory syncytial virus (RSV) and their effects on antibody susceptibility remain unclear. We analyzed AA substitutions in the main neutralizing epitopes of the F protein.
Methods
We analyzed F protein genes of 236 RSV strains isolated from children hospitalized with RSV infection in Fukushima, Japan (June 2008–February 2023). AA substitutions in antigenic sites II, V, and Ø were detected, and their effects on antibody susceptibility and viral replication were evaluated.
Results
Site II: The K272M (RSV-A) and the K272E (RSV-B) substitutions in strains from palivizumab-treated children reduced antibody susceptibility. Site V: In RSV-A, >50% of strains isolated since 2022 harbored the V178I substitution; however, this did not change antibody susceptibility. In RSV-B, L172Q/S173L mutant strains became predominant around 2016, leading to reduced antibody susceptibility. Site Ø: No AA substitutions were detected in RSV-A. In RSV-B, the I206M/Q209R mutant strain became predominant around 2018, leading to improved antibody susceptibility and replicative ability. However, none of the substitutions reduced antibody susceptibility.
Conclusions
The RSV F protein in Fukushima has naturally undergone AA substitutions with corresponding changes in antibody susceptibility, including unique regional patterns. Monitoring substitutions and antibody susceptibility is essential.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pediatrics, School of Medicine, Fukushima Medical University, Fukushima City.
- Department of Pediatrics, Hoshi General Hospital, Koriyama City.
- Department of Pediatrics, Soma General Hospital, Soma City.
- Department of Pediatrics, Shirakawa Kosei General Hospital, Shirakawa City.
- Department of Pediatrics, Ohara General Hospital, Fukushima City, Fukushima.
- Department of Virology 3, National Institute of Infectious Diseases, Tokyo, Japan.
ORCID-Profile: Hisao Okabe, Kazuya Shirato
Förderung
- Japan Agency for Medical Research and Development
Zitieren
APA
Okabe, H., Hashimoto, K., Norito, S., Asano, Y., Sato, M., Kume, Y., Chishiki, M., Maeda, H., Mashiyama, F., Takeyama, A., Murai, H., Nemoto, K., Ito, M., Suzuki, S., Sakuma, H., Shirato, K., Go, H., & Hosoya, M. (2025). Amino Acid Substitutions in the Fusion Protein of Respiratory Syncytial Virus in Fukushima, Japan, During 2008–2023 and Their Effects. The Journal of Infectious Diseases. https://doi.org/10.1093/infdis/jiae636
Vancouver
Okabe H, Hashimoto K, Norito S, Asano Y, Sato M, Kume Y, et al. Amino Acid Substitutions in the Fusion Protein of Respiratory Syncytial Virus in Fukushima, Japan, During 2008–2023 and Their Effects. The Journal of Infectious Diseases. 2025. doi:10.1093/infdis/jiae636
BibTeX
@article{Okabe2025,
author = {Okabe, Hisao and Hashimoto, Koichi and Norito, Sakurako and Asano, Yuichiro and Sato, Masatoki and Kume, Yohei and Chishiki, Mina and Maeda, Hajime and Mashiyama, Fumi and Takeyama, Aya and Murai, Hiromichi and Nemoto, Kenji and Ito, Masaki and Suzuki, Shigeo and Sakuma, Hiroko and Shirato, Kazuya and Go, Hayato and Hosoya, Mitsuaki},
title = {Amino Acid Substitutions in the Fusion Protein of Respiratory Syncytial Virus in Fukushima, Japan, During 2008–2023 and Their Effects},
journal = {The Journal of Infectious Diseases},
year = {2025},
doi = {10.1093/infdis/jiae636}
}
EUVIMED